Vaccine concept stocks include biology, biology, Wen's shares, Fosun Pharma, watson biological, Shanghai Pharmaceutical Co., Ltd., Changgaoke, Junshi Bio, Kangxinuo, Chongqing Beer, etc. 103 listed companies. What other vaccine-related stocks are brought by the following small series? Let's take a look, hoping to bring some reference.
What are the vaccine-related stocks?
1, Tiantan Bio (600 16 1): The company is mainly engaged in the research, production and management of biological products. 165438+ 10/8 closing news, Tiantan Bio closed at 24.660 yuan, up 9.99%. This year, the growth rate dropped by-19. 1%, with a total market value of 40.635 billion yuan.
2. Shenzhou Cell (688520): The company is engaged in biopharmaceuticals. 165438+1October 18 news, China Cell -U has increased by 37.54% this year, and the latest report is 94.270 yuan, up 9.36%, with a turnover of 399 million yuan.
3. Junshi Bio (688 180): The company's main business is biopharmaceuticals. As soon as the news of 165438+ 10/8 came out, the share price of Junshi Bio U5 rose by 3.33% in the day, and the latest price was 724 10 yuan, with 25,902,800 lots sold, with a total market value of 661.0/kl.
4. Kangxinuo (688 185): The company is engaged in the research and development and production of vaccines. 165438+1October 18 news, Kangxinuo's latest offer is 238.580 yuan, and its share price has risen by 8.84% in three days; Since the beginning of this year, the growth rate has dropped by-16.52% and the P/E ratio is 30.82.
5. Weiguang Bio (002880): The company mainly deals in biological products. 165438+1October 18 news, Weiguang Bio opened at 27.7 1 yuan and closed at 29.230 yuan. Within five days, the stock price rose by 4.86%, with a total market value of 6.629 billion yuan.
6. Jindike (688670): The company is engaged in research and development, production and sales of vaccines for human use. 165438+1October18th, Jindike opened at 50.45 yuan and closed at 52.500 yuan, up 5.02%. The highest price on that day was 54.65 yuan, and the lowest was 48.5 1 yuan, with 264 1000 lots, with a total market value of 4.62 billion yuan.
7. Hualan Vaccine (30 1207): The company is engaged in building materials, real estate, finance and medicine. 165438+1October 18 closing news, the share price of Hualan vaccine rose by 8.7 1% in five days, and the increase has dropped by -29.23% since this year. The latest price is 54.400 yuan, up by 4.43%, and the price-earnings ratio is 3/kloc-.
8. Yatai Group (60088 1): The company's main business is disposable medical devices. 165438+ 10/8 closing news, Yatai Group recently reported 2.680 yuan, up 4.28%. The turnover was 80.5775 million lots, with a total market value of 8.707 billion yuan.
Leading stock of animal vaccine listed company
1, Rip creature.
2. Kang Hua Biology.
3. Pleco.
1, Rip Bio (300119):165438+1October closing news 17, Rip Bio opened at 23.29 yuan and closed at 23.47 yuan. Within 7 days, the stock price rose by 7.67%, with a total market value of 9.49 billion yuan.
2. Kang Hua Biology (300841):165438+10/7. According to the closing news, Kang Hua Bio has increased by-14.98% this year. At the close, the stock fell 1.2 1% to 65438.
3. Pleco (603566):165438+1October 17 news, Pleco's share price rose by 2.3 1% in 7 days, with the latest price of 19.0 1 yuan.
4. Li Hai Bio (300 1 19): bibcock. Judging from the net profit in recent three years, the average net profit in recent three years is 14 125700 yuan, and the lowest net profit in recent three years is 8.927 million yuan in 2020 and the highest is 26558 yuan in 20 18 years. The company has a complete product line, strong R&D strength, leading technical service marketing model and leading market sales strength. Other animal vaccine stocks include: Aolian Electronics, Dabeinong, Bohui Innovation, Tianbang, Mingde Bio, Tiankang Bio, Jinhe Bio, Qianke Bio, Azure Bio, Zhongmu Co., Ltd., Luopu Pharmaceutical, Haizheng Pharmaceutical, Ruipu Bio, etc.
5. The concept of animal vaccine: The recent surge in pork in the market is mainly due to the global discovery of African swine fever virus, followed by the emergence of animal vaccine concept stocks. Recently, in September 10, China Academy of Agricultural Sciences released a message saying: Following the success of laboratory research in April this year, China made new and important progress in vaccine research and development in August this year. For the progress of an attenuated live vaccine with double gene deletion, laboratory safety evaluation and effectiveness test have been completed, breaking through the technical bottleneck of large-scale production. Recently, an application for biosafety assessment has been submitted to the Ministry of Agriculture and Rural Affairs, and it is about to enter the clinical trial stage. Now it is gradually entering autumn, which is the best season to prevent epidemics such as swine fever and influenza. At this time, the vaccine plays a very important role in ensuring that no epidemic occurs in winter and spring. Therefore, in the near future, the prospect of animal vaccine concept stocks may be better. Because of the influence of non-plague since last year, the concept of pig breeding in the market has changed, and the original concern about cost is gradually changing to the concern about safety and animal health.
6. Other animal vaccine concept stocks include: Bio, Mingde Bio, Pioneer Holdings, Tiankang Bio, Lihai Bio, Yongshun Bio, Qianke Bio, Dabeinong Bio, Jinhe Bio and Zhongmu Bio.
Leading stocks of vaccines rank in the top ten.
1 Shanghai Pharmaceutical Co., Ltd. is a stock issued by Shanghai Pharmaceutical Group Co., Ltd., and its subsidiary, Shanghai Crosslinking, specializes in the research and development of antibody-coupled drugs and the synthesis of small molecular drugs DM 1 by biological fermentation, with the stock code of 60 1607.
2. Plum blossom creatures
Meihua Bio is a stock issued by Meihua Biotechnology Group Co., Ltd., which holds a minority stake in Liaoning Aimei Biological Vaccine Technology Group Co., Ltd., engaged in vaccine research and development and production, with stock code 600873.
3. Tasly
Tasly is a stock issued by Tasly Holding Group Co., Ltd., and its subsidiary Jinna Bio undertakes the national influenza virus subunit vaccine project with stock code 600535.
4. Renfu Medicine
Renfu Medicine is a stock issued by Renfu Medicine Group Co., Ltd. As one of the top 100 enterprises in Hubei, the company ranks first in the province in terms of production capacity, dosage forms and resources, with the stock code of 600079.
5. Tiankang Biology
Tiankang Bio is a stock issued by Tiankang Bio-Co., Ltd. The business scope of the company includes the production and sales of veterinary drugs, additives, premixed feed and feed additives. The stock code is 002 100.
Biological vaccine leading stock
Longtou 1, Hualan Bio: The company is mainly engaged in the research and development, production and sales of blood products, vaccines and genetic engineering products.
Lead by 2. Boya Bio: The company mainly deals in blood products.
Lead by 3. Fosun Pharma: The company is mainly engaged in pharmaceutical manufacturing and research and development.
Watson biological: The company's main business is research and development, production and sales of biotechnological drugs such as vaccines for human use.
Lead by 5. Kangtai Bio: The company is mainly engaged in research and development, production and sales of vaccines for human use.
Recent situation of vaccine stock leader
Hualan Biology: Dragon Head
In the past five trading days, the biological life of Hualan increased by 1 1.22%, with the highest price of 2 1.48 yuan and the lowest price of 18.0 1 yuan, with a total market value of 4.397 billion yuan. 165438+1October 18 news, the net inflow of Hualan Bio's main funds was 30180,000 yuan, the net inflow of super-large single funds was 329 million yuan, and the net outflow of retail funds was 235 million yuan.
Boya creature: dragon head
In the past five trading days, Boya Bio rose for five consecutive days, during which the overall increase was 10.9438+0%. Compared with five trading days ago, the market value of Boya Bio increased by 65,438+09.31100 million yuan, up by 65,438+00.95438+0%. 165438+ 10/8 news, the net outflow of funds was 83.4573 million yuan, and the net outflow of oversized bills was 59.865438+0.8 million yuan, with a turnover of 966 million yuan.
Fosun Pharma: A Leading Company
In the past five trading days, the stock price rose by 8.27%, the highest in 39 yuan, and the total market value rose by 8.49 billion. 165438+1October 18 news, Fosun Pharma165438+1October/8, the net inflow of main funds was 753 million yuan, and the net inflow of super-large single funds was 599 million yuan.
Watson biological: The dragon head.
In the past five days, watson biological's share price rose by 9.52%, and its total market value increased by 765,438+92 million yuan. The current market value is 75.527 billion yuan. In 2022, the stock price fell-17.07%. In terms of capital flow data, in June, 5438+065438+ 10/8, the net inflow of main capital was1580,000 yuan, the net outflow of super-large single capital was 96 19200 yuan, and the net inflow of large single capital was1670,000 yuan.
Kangtai Biology: Longtou
In the past five trading days, the stock price rose by 5.98%, the highest price was 38.46 yuan, and the total market value rose by 2.544 billion yuan. 165438+1October 18, the net inflow of main funds of this stock was 495 1900 yuan, the net inflow of super-large single funds was 95,788,500 yuan, the net outflow of large single funds was 46,277,600 yuan and the net outflow of single funds was1602.
Hualan Biology (002007)
Hualan Bio released its financial report for the second quarter of 2022, achieving an operating income of 65.438+70.9 billion yuan, a year-on-year increase of 65.438+0.56.87%, and a net profit of 349 million yuan, a year-on-year increase of 72.86%. Earnings per share is 0. 19 yuan.
Boya Biology (300294)
Boya Bio released its financial report for the third quarter of 2022, achieving an operating income of 684 million yuan, a year-on-year increase of -4.55%, and a net profit of 654.38+39 billion yuan, a year-on-year increase of 654.38+00.89%; Earnings per share is 0.28 yuan.
Fosun Pharma (600 196)
Fosun Pharma released its financial report for the second quarter of 2022, achieving operating income of10.958 billion yuan, a year-on-year increase of 23. 18%, and net profit of10.85 billion yuan, a year-on-year increase of -33.66%. Earnings per share is 0.42 yuan.
Watsons (300 142)
Watsons Bio released its financial report for the third quarter of 2022, achieving an operating income of 65.438+35.8 million yuan, a year-on-year increase of 74.24%, and a net profit of 65.438+65.4 million yuan, a year-on-year increase of 654.38+0.35%; Earnings per share is 0.07 yuan.
Kangtai Bio (30060 1)
Kangtai Bio released its financial report for the third quarter of 2022, achieving an operating income of 737 million yuan, a year-on-year increase of -44.36%, and a net profit of 82.6443 million yuan, a year-on-year increase of-88.19%; Earnings per share is 0.07 yuan.